Anti-GFAP-antibody positive postinfectious acute cerebellar ataxia and myoclonus after COVID-19: a case report

We present a case of acute cerebellar ataxia and myoclonus with detected anti-GFAP-antibodies in a patient recently recovered from COVID-19. Main symptoms consisted of acute gait and limb ataxia and myoclonus. The patient improved considerably upon treatment with high-dose intravenous (IV) steroids....

Descripción completa

Detalles Bibliográficos
Autores principales: Asan, Livia, Klebe, Stephan, Kleinschnitz, Christoph, Stettner, Mark, Köhrmann, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Neurology in the Time of COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664296/
https://www.ncbi.nlm.nih.gov/pubmed/34899988
http://dx.doi.org/10.1177/17562864211062824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664296/
https://www.ncbi.nlm.nih.gov/pubmed/34899988
http://dx.doi.org/10.1177/17562864211062824

Ejemplares similares